|Awarded On||September 14, 2022|
|Title||CPRIT Early Clinical Investigator Award- Christopher Alvarez-Breckenridge|
|Award Mechanism||Early Clinical Investigator|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Giulio Draetta|
|Cancer Sites||Brain and Other Nervous System, Skin|
*Pending contract negotiation
As a surgeon-scientist with a background in translational therapeutics for tumors of the central nervous system (CNS), Dr. Christopher Alvarez-Breckenridge is focused on developing and implementing novel treatment approaches for this patient population. He has a long-standing interest in translational therapeutics which started during his MD/PhD training in the Medical Scientist Training Program at The Ohio State University while working in the laboratories of Dr. Antonio Chiocca and Dr. Michael Caligiuri. Under their mentorship, he studied the role of innate immunity in the context of oncolytic viral therapy for glioblastoma, making significant mechanistic discoveries related to natural ki...